Drug Topics
DECEMBER 5, 2022
Ann Anaya and Dean Kathleen Kennedy discuss the importance of diversity in pharmacy and why it matters that patients are treated by someone who looks them. Plus, Good Neighbor Pharmacy launches a scholarship program to help address these needs.
Pharmacy Times
DECEMBER 5, 2022
Coughing is a reflex predominantly mediated by control centers in respiratory areas of the brainstem, which is modulated by the cerebral cortex.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
DECEMBER 5, 2022
Short-term manufacturing problems are happening as the demand for Adderall and other stimulant medications for ADHD have increased. Data from Arrive Health show a marked increase in ADHD medication prescriptions for people in their 30s.
Pharmacy Times
DECEMBER 5, 2022
Jacinda Abdul-Mutakabbir, assistant professor of Pharmacy Practice at Loma Linda University, discusses how pharmacists can improve vaccination rates and learn from the pandemic.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
DECEMBER 5, 2022
Sydney Kirkpatrick, PharmD candidate, shares how pharmacy helped ease the burden of COVID-19 in rural areas of Nebraska.
Pharmacy Times
DECEMBER 5, 2022
Tenofovir alafenamide (Vemlidy; Gilead Science) approved for the treatment of chronic hepatitis B virus infection in pediatric patients aged 12 years and older with compensated liver disease.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
DECEMBER 5, 2022
Due to the correlation between virologic suppression and antiretroviral therapy adherence, understanding the impediments of adherence is of the utmost importance.
Drug Topics
DECEMBER 5, 2022
Providing culturally competent care is one way pharmacists can help improve vaccine uptake in their communities.
pharmaphorum
DECEMBER 5, 2022
A digital health assistant that can help people at risk of becoming dependent on alcohol has been launched in Belize, its first country, by the World Health Organisation (WHO) and Pan-American Health Organisation (PAHO). The artificial intelligence-powered assistant – called Pahola and available as a free online chat-based site – is designed to provide information and guidance to help people reduce their alcohol consumption, helping to prevent more than 200 health conditions linked to excessive
Drug Topics
DECEMBER 5, 2022
Immunocompromised adults aged 19 years or older are eligible to receive the recombinant zoster vaccine.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 5, 2022
Teplizumab is a humanized IgG1? Fc-nonbinding anti-CD3 monoclonal antibody that blocks T cells, preventing them from attacking beta cells.
STAT
DECEMBER 5, 2022
Next year, UnitedHealth Group — one of the largest health care companies on the planet — expects to make a lot more money in a relatively simple way: by funneling more of the insurance premiums it collects from workers and taxpayers toward itself. That’s possible because UnitedHealth, known for its sprawling insurance presence, has pivoted to become one of the largest providers of outpatient care by acquiring numerous physician practices, surgery centers, urgent care facilit
Pharmacy Times
DECEMBER 5, 2022
Although evidence suggests some deterioration for a few aspects of mental health, such as anxiety and behavioral problems, the overall findings were mixed with no clear pattern.
STAT
DECEMBER 5, 2022
Congress is considering two measures that modernize tools the Food and Drug Administration uses to oversee two areas of its vast portfolio: diagnostic tests and cosmetics. While the stakes are different for each of these industries, the basic premise driving these measures is the same. The FDA is currently working from an outdated regulatory playbook that has left gaps in its oversight of safety and effectiveness and makes it more difficult to introduce new innovations.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 5, 2022
Michelle Condren, PharmD, AE-C, BCPPS, CDCES, FPPA, discussed pharmacists' roles in inpatient diabetes management.
STAT
DECEMBER 5, 2022
Carlos David Castro Rojas was a healthy 27-year-old engineering student when he fell off a ladder hanging Christmas lights in 2017, breaking his leg and injuring his knee. What was supposed to be a relatively routine surgery at a Baylor Scott & White Health hospital in Dallas ultimately ended with Rojas sustaining a severe brain injury. His mother’s lawsuit alleges he wasn’t properly cared for while under general anesthesia, and the lack of blood flow and oxygen to his br
Pharmacy Times
DECEMBER 5, 2022
Atogepant is an oral calcitonin gene-related peptide receptor antagonist approved in 2021 for patients with episodic migraines.
STAT
DECEMBER 5, 2022
There’s a growing consensus among physicians and government regulators that pulse oximeters measure oxygen levels less accurately in patients with darker skin and need to be fixed. There’s another problem, however, that needs to be fixed first. Much of the work and research to understand the devices’ shortcomings and devise solutions is focused on race.
Pharmacy Times
DECEMBER 5, 2022
Muscle pain is a significant reason why many patients fail to remain adherent to their statin medication regimen.
Dr. Jamie Hardy: The Lifestyle Pharmacist
DECEMBER 5, 2022
Cozy, comfortable, and carefree are the feelings that come to mind when I think about my recent self-care hiatus. I packed my favorite duffel bag and headed off to a charming hideaway for the weekend. The best part is that I didn’t have to travel far. I escaped the hustle and bustle of my life as a pharmacist and entrepreneur in just a 15-minute drive to the Memphis Medical District.
Board Vitals - Pharmacist
DECEMBER 5, 2022
The holidays don’t necessarily mean shorter hours for physicians and other staff. People still get sick, still need surgery, and still arrive at the emergency room needing rapid care and life-saving treatments. Sometimes it’s necessary to bring the holidays to the hospital to enjoy them at all. That’s where decorations come in. If your medical facility allows for holiday decorations, you have a wide range of options to celebrate the season.
STAT
DECEMBER 5, 2022
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy was well-tolerated by patients with lung cancer — avoiding the serious liver side effects and treatment discontinuations that have stalled similar efforts by Amgen. The new safety data are a boost to Mirati’s efforts to expand the number of patients with KRAS-mutated lung cancer who might benefit from adagrasib — and help the drug grow into a commercial bl
Drug Store News
DECEMBER 5, 2022
The merchandising event will take place on Feb. 22 and focus on products across grocery and household, apparel, beach, tourism and general merchandise, among other categories.
STAT
DECEMBER 5, 2022
In the face of a national emergency in child and adolescent mental health, urgent measures are needed to help those in need. Many struggling youths and teens do not receive age-appropriate, timely, and affordable mental health care today. Training more mental health professionals is part of the solution, but that takes time. Digital health approaches can be developed more quickly, though they have not received the same kind of attention from investors as options for adult mental health, which ha
Pharmaceutical Technology
DECEMBER 5, 2022
Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub. According to the latest deal, the University of Queensland (UQ) and Griffith University will serve as foundational partners.
STAT
DECEMBER 5, 2022
The journal Cell is opening its own review of research co-authored by Stanford University president Marc Tessier-Lavigne, following new allegations about an altered image in a 1999 paper. Minor concerns had been raised about alleged alterations in three images in this paper in the past. And a journal spokesperson confirmed that Tessier-Lavigne contacted Cell about those issues in 2015.
Pharmaceutical Technology
DECEMBER 5, 2022
Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. In 2022, a surge in the pipeline has led to cannabinoid receptors becoming the most popular target in preclinical development. Despite this, the medical use of cannabinoid drugs is heavily restricted, including being banned in 137 countries, according to the United Nations.
STAT
DECEMBER 5, 2022
The study was a page-turner: Researchers at Google showed that an artificial intelligence system could predict acute kidney injury, a common killer of hospitalized patients, up to 48 hours in advance. The results were so promising that the Department of Veterans Affairs, which supplied de-identified patient data to help build the AI, said in 2019 that it would immediately start work to bring it to the bedside.
Drug Store News
DECEMBER 5, 2022
CVS is using technology, including robotics, automation, machine learning and artificial intelligence, across more than 9,000 stores.
STAT
DECEMBER 5, 2022
In the fight to command the growing market for telehealth, Thirty Madison is staking out new terrain. Over the last year and a half, the 5-year-old digital health startup has been quietly planning to expand into sleep care with a new brand called River. Thirty Madison has been challenged to distinguish itself from direct-to-consumer companies like Hims and Ro, which also provide a combination of digital pharmacy services and telehealth — often bolstered by significant advertising budgets.
European Pharmaceutical Review
DECEMBER 5, 2022
Novartis has announced its Phase III PSMAfore study with Pluvicto , lutetium (177Lu) vipivotide tetraxetan, demonstrated improved radiographic progression-free survival (rPFS) in patients with prostate-specific membrane antigen (PSMA)–positive metastatic castration-resistant prostate cancer (mCRPC) after androgen-receptor pathway inhibitor (ARPI) therapy, compared to a change in ARPI.
Fierce Healthcare
DECEMBER 5, 2022
KFF: For-profit hospital system margins surge past pre-pandemic levels. rking. Mon, 12/05/2022 - 16:05.
Pharmafile
DECEMBER 5, 2022
Amgen Inc’s new obesity drug has appeared promising in its small phase 1 trial, meaning they will be able to go ahead with a larger mid-stage trial in 2023. The trial demonstrated that patients were able to maintain their weight loss for 70 days following the highest dose of the drug, known as AMG133. Amgen have announced that the highest monthly dose of AMG133 resulted in a mean weight loss of 14.5% after 12 weeks, however the patients’ average maintained weight loss fell to 11.2% after 150 day
Pharmacy Times
DECEMBER 5, 2022
Implementing screening tools, conducting brief interventions, and involving pharmacists can help manage alcohol use disorder and Alcohol Withdrawal Syndrome.
Expert insights. Personalized for you.
211 
Let's personalize your content